Cry61 gene therapy induces angiogenesis to mitigate myocardial infarction effects

Article

CONTEXT: Previous studies have shown that Cry61, a cysteine-rich gene, can induce angiogenesis to improve arterial flow in rabbits with ischemic limb disease. A swine study demonstrated that neovasculature resulting from the infusion of the gene boosts myocardial blood flow to treat myocardial infarction. Nuclear physician Dr. Pascal Merlet and colleagues in the nuclear medicine department of Hopital Bichat in Paris and the cardiology department of Hopital Universitaire Henri Mondor in Creteil, France, performed the experiment.

RESULTS: Seven pigs with artificially produced myocardial infarction were treated with an epicardial injection of 5 x 108 infectious units of an adenovirus carrying the therapeutic Cyr61 gene. As a control, seven other pigs with artificial infarcts received adenovirus without the agent. Stress-rest technetium-99m sestamibi SPECT perfusion performed four weeks later found a significant decrease in the extent and mean intensity of ischemic defects in the animals treated with the Cyr61 gene compared with the controls (p = 0.02).

IMPLICATIONS: Merlet concluded that the Cyr61 gene transfer stimulates myocardial angiogenesis, prompting great improvement in myocardial perfusion measured with standard SPECT imaging. The findings strengthen the case for Cyr61 as a therapeutic candidate to reverse severe myocardial ischemia.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.